Sam Blackman

Oncologist and Entrepreneur

Sam is the co-founder and former Head of Research & Development of Day One Biopharmaceuticals. He is a physician-scientist trained in pediatric hematology/oncology and neuro-oncology, and has led the early clinical development of more than 10 novel cancer therapeutics. Prior to founding Day One, Dr. Blackman was Head of Clinical Development at Mavupharma, Head of Clinical Development at Silverback Therapeutics, and held roles at Juno Therapeutics, Seattle Genetics, Merck, and GlaxoSmithKline. Dr. Blackman is a graduate of the pediatric hematology/oncology fellowship programme at the Dana-Farber Cancer Institute and Children’s Hospital Boston, and the pediatric residency programme at Cincinnati Children’s Hospital Medical Centre. He received his MD and PhD degrees from the University of Illinois at Chicago, and his undergraduate degree in Philosophy from the University of Chicago.